Institutional investors hold a majority ownership of ACT through the 103.70% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Generic industry. Last, during the quarter ended June 2014, these large investors purchased a net $7.6 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FIDELITY MANAGEMENT & RESEARCH C... Bought 4.3 Million shares of Actavis PLC
FARALLON CAPITAL MANAGEMENT LLC Bought 3.2 Million shares of Actavis PLC
DAVIDSON KEMPNER CAPITAL MANAGEM... Bought 1.9 Million shares of Actavis PLC